 | Up a level |
Number of items: 1.
Faatz, H., Feltgen, N., Gutfleisch, M., Heimes-Bussmann, B., Krohne, T. U., Liakopoulos, S., Liegl, R., Lommatzsch, A., Mussinghoff, P., Rehak, M., Schmitz-Valckenberg, S., Spital, G., Stanzel, B., Ziemssen, F., Haegele, B., Junkes, C., Porstner, M., Voegeler, J., Gmeiner, B. and Pauleikhoff, D. (2023). Prospective noninterventional BLUE SKY study evaluating the efficacy of brolucizumab in treatment-naive and previously treated patients with neovascular AMD. Ophthalmologie, 120 (3). S. 294 - 301. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7218